Crossmark

What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events

Crossref DOI link: https://doi.org/10.1016/j.aller.2018.04.005

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Miranda Poma, Jesus

Ostios Garcia, Lorena

Villamayor Sanchez, Julia

D’errico, Gabriele
License Information

Text and Data Mining valid from 2019-05-01
More Information

This article is maintained by: Elsevier

Article Title: What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events

Journal Title: Allergologia et Immunopathologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aller.2018.04.005

Content Type: article

Copyright: © 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.